Stay updated with breaking news from Factor Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A report from brokerage firm Sharekhan highlighted key factors contributing to Cipla's upward trajectory, emphasizing the company's strategic focus on complex products and the resultant impact on margins.
In a dynamic trading session on Friday, the Nifty managed to recover, reclaiming the 21,790 mark, while the Sensex recorded modest gains of approximately 150 points. However, the broader market indices, particularly the midcap and smallcap indices, faced downward pressure, each declining by 1%.
On Thursday, 1636 stocks advanced, 2,204 declined, and 105 remained unchanged on BSE with an advance decline ratio of 0.74, indicating a negative closing of stocks in broader markets.
Pharma major Cipla has generated considerable interest from private equity players. What makes it such an alluring prospect, and what does the future hold for this storied company? - Issue Date: Oct 29, 2023
With the possibility of Bain Capital and Dr Reddy's entry in the race to acquire promoter's stake in Cipla, competition has now intensified as firms like Torrent Pharma and Blackstone have already placed their respective bids